CRISPR TherapeuticsCRSP 
$49.59-0.56%24h
-0.56%24h
Global rank3298
Market cap$3.94B
Change 7d1.27%
YTD Performance-19.81%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of CRISPR Therapeutics (CRSP)
As of November 2024, CRISPR Therapeutics has a market cap of $3.94B. This makes CRISPR Therapeutics the world's 3298th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of CRISPR Therapeutics from 2016 to 2024
-
Value:-
Market cap history of CRISPR Therapeutics from 2016 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $6.69B | 34.46% |
| 2023 | $4.97B | 54.00% |
| 2022 | $3.23B | -46.36% |
| 2021 | $6.02B | -50.51% |
| 2020 | $12.16B | 151.39% |
| 2019 | $4.84B | 113.18% |
| 2018 | $2.27B | 21.68% |
| 2017 | $1.87B | 15.89% |
| 2016 | $1.61B | - |
CRSP Market Cap Today is $3.94B -0.56% - 21 Nov 2024
View largest stocks by market cap 
